HIV capsid inhibitor may offer long-term viral suppression
One in six South Africans drug resistant before starting HIV treatment
Are CD4 counts still useful in the 'treat all' era?
Multiple benefits to scaling up universal test and treat in Africa
Long-acting injectable treatment maintains viral suppression
Integrase inhibitor treatment leads to greater weight gain
How many people who have used PrEP get HIV the same year? New York study finds out
The length of time Americans with HIV remain infectious is falling, but slowly
Neural tube defects and integrase inhibitors: still waiting for stronger evidence
